Epigral Limited (EPIGRAL) fundamentals
Epigral Limited is a listed company in Chemicals & Petrochemicals, part of the Chemicals sector, listed on the NSE as EPIGRAL (ISIN INE071N01016). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Epigral Limited does
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. The Company operates in a single segment, which primarily relates to the manufacturing of Chlor Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as, alumina, pharmaceuticals, textiles, agrochemicals, epoxy resins, paints and coatings, paper and pulp, PU foams, CPVC pipes and fittings, construction, refineries, soaps, detergents, and others.
Valuation and market data
| Last close | ₹1149.50 |
|---|---|
| Market capitalisation | ₹4,959 crore |
| Enterprise value | ₹5,527 crore |
| P/E (TTM) | 14.94 |
| Price to book | 2.23 |
| Price to sales (TTM) | 1.12 |
| Book value per share | ₹514.92 |
| Dividend yield | 43.50% |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Listed since | Wed Aug 18 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹2,542 crore | ₹341 crore | ₹332 crore | 76.95 |
| Mar 2025 | ₹2,565 crore | ₹541 crore | ₹358 crore | 84.68 |
| Mar 2024 | ₹1,936 crore | ₹291 crore | ₹196 crore | 47.14 |
| Mar 2023 | ₹2,196 crore | ₹522 crore | ₹353 crore | 85.03 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 68.8% |
|---|---|
| Foreign institutions (FII) | 1.0% |
| Mutual funds | 5.5% |
| Other domestic institutions | 0.0% |
| Retail and others | 24.6% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.